학술논문
Nivolumab and Relatlimab in Patients with Advanced Melanoma That Had Progressed on Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy: Results from the Phase I/IIa RELATIVITY-020 Trial
Document Type
Article
Author
Ascierto, P.A.; Lipson, E.J.; Dummer, R.; Larkin, J.; Long, G.V.; Sanborn, R.E.; Chiarion-Sileni, V.; Dréno, B.; Dalle, S.; Schadendorf, D.; Callahan, M.K.; Nyakas, M.; Atkinson, V.; Gomez-Roca, C.A.; Yamazaki, N.; Tawbi, H.A.; Sarkis, N.; Warad, D.; Dolfi, S.; Mitra, P.; Suryawanshi, S.; Grob, J.-J.
Source
In: Journal of Clinical Oncology . (Journal of Clinical Oncology, 20 May 2023, 41(15):2724-2735)
Subject
Language
English
ISSN
15277755
0732183X
0732183X